“TURKOVAC” Phase-III Meeting with Kyrgyzstan
TUSEB Deputy Secretary General Prof. Dr. Figen Çizmeci Şenel, Director of TUSEB Turkish Vaccine Institute Prof. Dr. Ateş Kara, Head of TUSEB Project Management and Support Department Exp. Batuhan Yeşilyurt, Experts of TUSEB Clinical Research Centre, CEO of Omega CRO Berk Özdemir had a meeting with the officials of Ministry of Health of Kyrgyzstan via videoconference.
Phase-III studies of first domestic inactive COVID-19 vaccine “TURKOVAC” developed by TUSEB were discussed during the meeting.